Literature DB >> 17314157

Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein.

Kimberly Meade-White1, Brent Race, Matthew Trifilo, Alex Bossers, Cynthia Favara, Rachel Lacasse, Michael Miller, Elizabeth Williams, Michael Oldstone, Richard Race, Bruce Chesebro.   

Abstract

Prion protein (PrP) is a required factor for susceptibility to transmissible spongiform encephalopathy or prion diseases. In transgenic mice, expression of prion protein (PrP) from another species often confers susceptibility to prion disease from that donor species. For example, expression of deer or elk PrP in transgenic mice has induced susceptibility to chronic wasting disease (CWD), the prion disease of cervids. In the current experiments, transgenic mice expressing two naturally occurring allelic variants of deer PrP with either glycine (G) or serine (S) at residue 96 were found to differ in susceptibility to CWD infection. G96 mice were highly susceptible to infection, and disease appeared starting as early as 160 days postinfection. In contrast, S96 mice showed no evidence of disease or generation of disease-associated protease-resistant PrP (PrPres) over a 600-day period. At the time of clinical disease, G96 mice showed typical vacuolar pathology and deposition of PrPres in many brain regions, and in some individuals, extensive neuronal loss and apoptosis were noted in the hippocampus and cerebellum. Extraneural accumulation of PrPres was also noted in spleen and intestinal tissue of clinically ill G96 mice. These results demonstrate the importance of deer PrP polymorphisms in susceptibility to CWD infection. Furthermore, this deer PrP transgenic model is the first to demonstrate extraneural accumulation of PrPres in spleen and intestinal tissue and thus may prove useful in studies of CWD pathogenesis and transmission by oral or other natural routes of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314157      PMCID: PMC1900179          DOI: 10.1128/JVI.02762-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Introduction to the transmissible spongiform encephalopathies or prion diseases.

Authors:  Bruce Chesebro
Journal:  Br Med Bull       Date:  2003       Impact factor: 4.291

2.  PrP genotypes of captive and free-ranging Rocky Mountain elk (Cervus elaphus nelsoni) with chronic wasting disease.

Authors:  K I O'Rourke; T E Besser; M W Miller; T F Cline; T R Spraker; A L Jenny; M A Wild; G L Zebarth; E S Williams
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

3.  Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue.

Authors:  K I O'Rourke; T V Baszler; T E Besser; J M Miller; R C Cutlip; G A Wells; S J Ryder; S M Parish; A N Hamir; N E Cockett; A Jenny; D P Knowles
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice.

Authors:  E Flechsig; D Shmerling; I Hegyi; A J Raeber; M Fischer; A Cozzio; C von Mering; A Aguzzi; C Weissmann
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

5.  Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans.

Authors:  R Race; A Raines; G J Raymond; B Caughey; B Chesebro
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Passage of chronic wasting disease prion into transgenic mice expressing Rocky Mountain elk (Cervus elaphus nelsoni) PrPC.

Authors:  Giuseppe LaFauci; Richard I Carp; Harry C Meeker; Xuemin Ye; Jae I Kim; Michael Natelli; Marisol Cedeno; Robert B Petersen; Richard Kascsak; Richard Rubenstein
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

7.  Polymorphisms in the prion precursor functional gene but not the pseudogene are associated with susceptibility to chronic wasting disease in white-tailed deer.

Authors:  Katherine I O'Rourke; Terry R Spraker; Linda K Hamburg; Thomas E Besser; Kelly A Brayton; Donald P Knowles
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

8.  Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.

Authors:  Victoria A Lawson; Suzette A Priola; Kimberly Meade-White; McKinley Lawson; Bruce Chesebro
Journal:  J Biol Chem       Date:  2004-01-21       Impact factor: 5.157

9.  A processed pseudogene contributes to apparent mule deer prion gene heterogeneity.

Authors:  Kelly A Brayton; Katherine I O'Rourke; Amy K Lyda; Michael W Miller; Donald P Knowles
Journal:  Gene       Date:  2004-02-04       Impact factor: 3.688

10.  Prion disease: horizontal prion transmission in mule deer.

Authors:  Michael W Miller; Elizabeth S Williams
Journal:  Nature       Date:  2003-09-04       Impact factor: 49.962

View more
  44 in total

1.  Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Bruce Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 2.  Nucleic acid-free mutation of prion strains.

Authors:  Glenn C Telling
Journal:  Prion       Date:  2010-10-19       Impact factor: 3.931

Review 3.  Molecular Mechanisms of Chronic Wasting Disease Prion Propagation.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

4.  Prion 2015 poster abstracts.

Authors: 
Journal:  Prion       Date:  2015       Impact factor: 3.931

5.  Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice.

Authors:  James A Carroll; Brent Race; Katie Phillips; James F Striebel; Bruce Chesebro
Journal:  J Gen Virol       Date:  2017-07-31       Impact factor: 3.891

Review 6.  Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.

Authors:  Julie A Moreno; Glenn C Telling
Journal:  Methods Mol Biol       Date:  2017

7.  Prion transmission prevented by modifying the β2-α2 loop structure of host PrPC.

Authors:  Timothy D Kurt; Cyrus Bett; Natalia Fernández-Borges; Shivanjali Joshi-Barr; Simone Hornemann; Thomas Rülicke; Joaquín Castilla; Kurt Wüthrich; Adriano Aguzzi; Christina J Sigurdson
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

8.  Prion disease tempo determined by host-dependent substrate reduction.

Authors:  Charles E Mays; Chae Kim; Tracy Haldiman; Jacques van der Merwe; Agnes Lau; Jing Yang; Jennifer Grams; Michele A Di Bari; Romolo Nonno; Glenn C Telling; Qingzhong Kong; Jan Langeveld; Debbie McKenzie; David Westaway; Jiri G Safar
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

9.  Fatal transmissible amyloid encephalopathy: a new type of prion disease associated with lack of prion protein membrane anchoring.

Authors:  Bruce Chesebro; Brent Race; Kimberly Meade-White; Rachel Lacasse; Richard Race; Mikael Klingeborn; James Striebel; David Dorward; Gillian McGovern; Martin Jeffrey
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

10.  Susceptibilities of nonhuman primates to chronic wasting disease.

Authors:  Brent Race; Kimberly D Meade-White; Michae W Miller; Kent D Barbian; Richard Rubenstein; Giuseppe LaFauci; Larisa Cervenakova; Cynthia Favara; Donald Gardner; Dan Long; Michael Parnell; James Striebel; Suzette A Priola; Anne Ward; Elizabeth S Williams; Richard Race; Bruce Chesebro
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.